Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk-Reference-Cited by-同舟云学术

Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk

Published:2022-07-23 Issue:11 Volume:16 Page:131-144
ISSN:1932-9520
Container-title:Current Cardiovascular Risk Reports
language:en
Short-container-title:Curr Cardiovasc Risk Rep

Author:

Bharadiya Vishwesh M.,Rawal Swasti,Jain Vardhmaan,Chevli Parag A.,Mehta Anurag^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s12170-022-00702-1.pdf

Reference111 articles.

1. Castillo-Núñez Y, Morales-Villegas E, Aguilar-Salinas CA. Triglyceride-rich lipoproteins: their role in atherosclerosis. Rev Investig Clínica. 2022;74:61–70.

2. • Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2022;19:168–79. (Comprehensive review focusing on the metabolism of TRL, remnants, and other apolipoproteins and their role in atherosclerosis)

3. •• Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791–806. (Recent consensus statement from the European Atherosclerosis Society that discusses all aspects of TRL and remnant biology, pathophysiology, clinical measurement, and therapies)

4. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118:547–63.

5. Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res. 2011;52:189–206.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies;Diabetes Research and Clinical Practice;2024-05